Published in:
01-10-2021 | Positron Emission Tomography | Editorial
Advances in cardiac PET/MR imaging: Facilitating cutting-edge structural and biological phenotyping of the cardiovascular system
Authors:
Ahmed Tawakol, MD, Georges El Fakhri, PhD, Ciprian Catana, MD, PhD, David E. Sosnovik, MD
Published in:
Journal of Nuclear Cardiology
|
Issue 5/2021
Login to get access
Excerpt
The past decade has seen a dramatic increase in the clinical adoption of cardiac positron emission tomography (PET). Integrated PET and computed tomography (PET–CT) is now routinely used to assess myocardial perfusion and to evaluate for myocardial viability, cardiac sarcoidosis and infections. In the next decade, we believe that the clinical utility of cardiac PET imaging will continue to grow, facilitated by innovations in two key areas: (1) the development of novel targeted tracers of several molecular pathways, and (2) improvements in imaging hardware and reconstruction techniques. Among developments in instrumentation, integrated PET and magnetic resonance imaging (PET–MRI) scanners represents one of the most exciting opportunities. …
